Literature DB >> 7762850

Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme.

Z X Fang1, E I Eger, M J Laster, B S Chortkoff, L Kandel, P Ionescu.   

Abstract

Anecdotal reports suggest that soda lime and Baralyme brand absorbent can degrade inhaled anesthetics to carbon monoxide (CO). We examined the factors that govern CO production and found that these include: 1) The anesthetic used: for a given minimum alveolar anesthetic concentration (MAC)-multiple, the magnitude of CO production (greatest to least) is desflurane > or = enflurane > isoflurane >> halothane = sevoflurane. 2) The absorbent dryness: completely dry soda lime produces much more CO than absorbent with just 1.4% water content, and soda lime containing 4.8% or more water (standard soda lime contains 15% water) generates no CO. In contrast, both completely dry Baralyme and Baralyme with 1.6% water produce high concentrations of CO, and Baralyme containing 4.7% water produces concentrations equaling those produced by soda lime containing 1.4% water. Baralyme containing 9.7% or more water and standard Baralyme (13% water) do not generate CO.3) The type of absorbent: at a given water content, Baralyme produces more CO than does soda lime. 4) The temperature: an increased temperature increases CO production. 5) The anesthetic concentration: more CO is produced from higher anesthetic concentrations. These results suggest that CO generation can be avoided for all anesthetics by using soda lime with 4.8% (or more) water or Baralyme with 9.7% (or more) water, and by using inflow rates of less than 2-3 L/min. Such inflow rates are low enough to ensure that the absorbent does not dry out.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762850     DOI: 10.1097/00000539-199506000-00021

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  26 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  General anesthesia in cardiac surgery: a review of drugs and practices.

Authors:  Cory M Alwardt; Daniel Redford; Douglas F Larson
Journal:  J Extra Corpor Technol       Date:  2005-06

3.  [Low-flow anesthesia with desflurane].

Authors:  J Baum; M Berghoff; H G Stanke; M Petermeyer; G Kalff
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

Review 4.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 5.  Inhaled anesthetics in horses.

Authors:  Robert J Brosnan
Journal:  Vet Clin North Am Equine Pract       Date:  2013-01-18       Impact factor: 1.792

6.  Functional closed-system anesthesia using a function-equipped anesthesia machine and time-cycled ventilator.

Authors:  Kazutoshi Okada; Naoko Asano; Hiroto Nakayama; Hiroshi Okada
Journal:  J Anesth       Date:  1998-06       Impact factor: 2.078

7.  Carbon dioxide absorbents: does it matter which one you use?

Authors:  Jeffrey M Feldman
Journal:  J Clin Monit Comput       Date:  2018-01-10       Impact factor: 2.502

8.  The safety and efficacy of minimal-flow desflurane anesthesia during prolonged laparoscopic surgery.

Authors:  Sang Yoong Park; Chan Jong Chung; Jung Hoon Jang; Jae Young Bae; So Ron Choi
Journal:  Korean J Anesthesiol       Date:  2012-12-14

Review 9.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

Review 10.  Carbon monoxide and anesthesia-induced neurotoxicity.

Authors:  Richard J Levy
Journal:  Neurotoxicol Teratol       Date:  2016-09-09       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.